stella
beta
Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors — Stella
Recruiting
Back to Small Bowel Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(5 sites)
United States
Moffitt Cancer Center, Tampa, Florida
University of Illinois Cancer Center, Chicago, Illinois
Washington University School of Medicine, St Louis, Missouri
Atlantic Health System, Morristown, New Jersey
Virginia Commonwealth University, Richmond, Virginia
View full record on ClinicalTrials.gov